Vical Overview

  • Founded

  • 1987

Founded
  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • M&A

Vical General Information

Description

Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000 and BBI-6000 among others.

Contact Information

Website
www.vical.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Drug Delivery
Acquirer
Brickell Biotech
Primary Office
  • 10390 Pacific Center Court
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 03-Sep-2019 00000 Completed Generating Revenue
11. Secondary Transaction - Open Market 00000 Completed Generating Revenue
10. 2PO 05-Jan-2012 0000 00000 Completed Generating Revenue
9. PIPE 08-Jan-2010 0000 00000 Completed Generating Revenue
8. PIPE 30-Jul-2009 0000 000.00 Completed Generating Revenue
7. PIPE 26-May-2009 0000 000.00 Completed Generating Revenue
6. PIPE 22-May-2009 000.00 000.00 Completed Generating Revenue
5. PIPE 23-Jun-2008 000.00 000.00 Completed Generating Revenue
4. PIPE 01-Oct-2006 $12.5M $26.5M Completed Generating Revenue
3. 2PO 23-Jul-1993 $14M $14M Completed Generating Revenue
To view Vical’s complete valuation and funding history, request access »

Vical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics f
Biotechnology
San Diego, CA
00000
000000&0 00000

000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repre
0000000000000
Plymouth Meeting, PA
000 As of 0000
000.00
00000000 000.00

000000

um dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
0000 000000000
San Diego, CA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vical Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
0000000 Formerly VC-backed San Diego, CA 00 00000 000000000 00000
000000 00000000000 Formerly VC-backed Boston, MA 0000 00.000 000000&0
000000 Corporation Durham, NC 00 000.00 000000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
You’re viewing 5 of 26 competitors. Get the full list »

Vical Patents

  • 161

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Vical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130273078-A1 Synergistic anti-tumor efficacy using alloantigen combination immunotherapy Abandoned 20-Sep-2011 00000000000
AU-2013201121-A1 Synergistic anti-tumor efficacy using alloantigen combination immunotherapy Abandoned 20-Sep-2011 00000000000
US-20130071403-A1 Synergistic anti-tumor efficacy using alloantigen combination immunotherapy Abandoned 20-Sep-2011 00000000000
US-20130280265-A1 Synergistic anti-tumor efficacy using alloantigen combination immunotherapy Abandoned 20-Sep-2011 00000000000
GB-2461832-A Methods of treating measles infectious disease in mammals Withdrawn 29-May-2007 C07K14/005 0
To view Vical’s complete patent history, request access »

Vical Executive Team (9)

Name Title Board Seat Contact Info
Adam Levy Executive
You’re viewing 1 of 9 executive team members. Get the full list »

Vical Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Azimuth Opportunity Investment Bank Minority 000 0000 000000 0
Federated Kaufmann Fund Mutual Fund Minority 000 0000 000000 0
Mentor Capital Mezzanine Minority 000 0000 000000 0
Morgenthaler Ventures Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Vical Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 03-Sep-2019 0000000 00 Drug Delivery
00000 00 01-Jun-2006 0000 000.00 Biotechnology
Inovio Pharmaceuticals 03-Jan-2006 PIPE 000.00 Biotechnology
To view Vical’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Vical Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 0000000 03-Sep-2019 0000000 000000 Completed
  • 00000
00000 00 01-Jun-2006 0000 000.00 Completed
  • 00000
Inovio Pharmaceuticals 03-Jan-2006 PIPE 000.00 Completed
  • 2 buyers
To view Vical’s complete exits history, request access »